- Home
- GTBP vs POLA Comparison
GTBP vs POLA Comparison
Compare GTBP & POLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTBP
- POLA
- Stock Information
- Founded
- GTBP 1965
- POLA 1979
- Country
- GTBP United States
- POLA United States
- Employees
- GTBP N/A
- POLA N/A
- Industry
- GTBP Biotechnology: Pharmaceutical Preparations
- POLA Industrial Machinery/Components
- Sector
- GTBP Health Care
- POLA Miscellaneous
- Exchange
- GTBP Nasdaq
- POLA Nasdaq
- Market Cap
- GTBP 6.6M
- POLA 7.7M
- IPO Year
- GTBP N/A
- POLA 2016
- Fundamental
- Price
- GTBP $2.91
- POLA $0.46
- Analyst Decision
- GTBP
- POLA
- Analyst Count
- GTBP 0
- POLA 0
- Target Price
- GTBP N/A
- POLA N/A
- AVG Volume (30 Days)
- GTBP 28.9K
- POLA 161.1K
- Earning Date
- GTBP 11-14-2024
- POLA 11-14-2024
- Dividend Yield
- GTBP N/A
- POLA N/A
- EPS Growth
- GTBP N/A
- POLA N/A
- EPS
- GTBP N/A
- POLA N/A
- Revenue
- GTBP N/A
- POLA $14,953,000.00
- Revenue This Year
- GTBP N/A
- POLA $6.72
- Revenue Next Year
- GTBP N/A
- POLA N/A
- P/E Ratio
- GTBP N/A
- POLA N/A
- Revenue Growth
- GTBP N/A
- POLA N/A
- 52 Week Low
- GTBP $1.92
- POLA $0.32
- 52 Week High
- GTBP $10.66
- POLA $0.90
- Technical
- Relative Strength Index (RSI)
- GTBP 55.53
- POLA 49.27
- Support Level
- GTBP $2.94
- POLA $0.43
- Resistance Level
- GTBP $3.54
- POLA $0.53
- Average True Range (ATR)
- GTBP 0.27
- POLA 0.05
- MACD
- GTBP -0.02
- POLA 0.00
- Stochastic Oscillator
- GTBP 23.05
- POLA 45.07
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
About POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications primarily in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, Back-up DC generators, hybrid power systems, Li-Ion battery systems, and Marine DC generators. The Companie's geographical presence is in the United States, Canada, Mexico, South Pacific Islands, Japan, Europe and Middle East and Other Asia Pacific countries.